Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: FEMYNOR — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approves a supplemental application for FEMYNOR, a generic oral contraceptive containing norgestimate and ethinyl estradiol, from Amneal Pharmaceuticals NY …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL)